This could be overcome using synthetic (Syn)Notch technology, whereby expression of the ROR1 CAR was driven by recognition of a target (B7-H3 or EpCAM) that was found on tumour cells but not stromal cells [47]. Here, ROR1 is linked to neoplasm.